H-ELVSEFSR^-OH

Ref. 3D-PP48875

Produktinformation

• Name: H-ELVSEFSR^-OH

Beschreibung

Peptide H-ELVSEFSR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ELVSEFSR^-OH include the following: Quantification of HER2 from gastroesophageal cancer (GEC) FFPE tissue by mass spectrometry (MS). TA Hembrough, L Henderson, B Rambo, WL Liao - 2014 - ascopubs.orghttps://ascopubs.org/doi/abs/10.1200/jco.2014.32.3_suppl.17 Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue T Hembrough, S Thyparambil, WL Liao - The Journal of Molecular , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1525157813000561 The addition of FAIMS increases targeted proteomics sensitivity from FFPE tumor biopsies S Sweet , D Chain, W Yu, P Martin, M Rebelatto - Scientific Reports, 2022 - nature.comhttps://www.nature.com/articles/s41598-022-16358-1 High-Field Asymmetric Waveform Ion Mobility Spectrometry and Parallel Reaction Monitoring Increases Sensitivity for Clinical Biomarker Quantitation from Formalin S Sweet , D Chain, W Yu, P Martin, M Rebelatto - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.02.08.479554.abstract Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue RW Sprung, MA Martinez, KL Carpenter - Journal of proteome , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr300130t High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy P Nuciforo , S Thyparambil, C Aura , A Garrido-Castro - Molecular , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1574789115001611 Quantitative analysis of HER family proteins using mass spectrometry as a predictive tool of response to anti-HER therapies in breast cancer P Nuciforo - 2016 - ddd.uab.cathttps://ddd.uab.cat/record/169257 Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer M Moutafi , CJ Robbins , V Yaghoobi - Laboratory , 2022 - nature.comhttps://www.nature.com/articles/s41374-022-00804-9 How may targeted proteomics complement genomic data in breast cancer? M Guerin, A Gonacahttps://www.tandfonline.com/doi/abs/10.1080/14789450.2017.1256776 Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH DVT Catenacci , WL Liao, L Zhao , E Whitcomb - Gastric Cancer, 2016 - Springerhttps://link.springer.com/article/10.1007/s10120-015-0566-0 Application of tissue mesodissection to molecular cancer diagnostics D Krizman, N Adey, R Parry - Journal of Clinical Pathology, 2015 - jcp.bmj.comhttps://jcp.bmj.com/content/68/2/166.short Species Contribution Reference Number CAG NAG, EGC IM, CAG GC - , Functional Mechanisms, and , 2023 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=prrjEAAAQBAJ&oi=fnd&pg=PA424&dq=(%22H-ELVSEFSR%5E-OH%22+OR+%22H-ELVSEFSR-OH%22+OR+%22ELVSEFSR%5E%22+OR+%22ELVSEFSR%22)+AND+peptide&ots=oR0eTtPIQb&sig=2JJuzsQTp_i07Ce7siYSGOkA4oc Species Contribution Reference Number CAG NAG, EGC IM, CAG GC - , Functional Mechanisms, and , 2023 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=prrjEAAAQBAJ&oi=fnd&pg=PA424&dq=(%22H-ELVSEFSR%5E-OH%22+OR+%22H-ELVSEFSR-OH%22+OR+%22ELVSEFSR%5E%22+OR+%22ELVSEFSR%22)+AND+peptide&ots=oR0eTtPIV9&sig=pTauq2lYj-QKQE1trDq14AwxcJo Isotopologue multipoint calibration for proteomics biomarker quantification in clinical practice C Chiva , O Pastor, L Trilla-Fuertes - Analytical , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.8b05802 A comparative study of gastric adenocarcinoma Her2 Ihc phenotype and mass spectrometry-based quantification B Xu, H Chen, J Zhang, Y Cong, L Ning, L Chen - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2023.1152895/full Companion and complementary diagnostics by mass spectrometry AR Blackler, MW Duncan - Companion and complementary diagnostics, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780128135396000092 Development of multiple reaction monitoring (MRM) assays to identify Brucella abortus proteins in the serum of humans and livestock AA Husain, SM Pinto , Y Subbannayya - PROTEOMICS , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.202200009

• Marke: Biosynth